Literature DB >> 35703764

Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care.

Sarita Sonalkar1, Arden McAllister1, Corinne Kete1, Jessica Fishman2,3, Alhambra Frarey1, William R Short4, Courtney A Schreiber1, Anne Teitelman5.   

Abstract

BACKGROUND: Family planning and abortion clinics routinely address sexual health. We sought to evaluate implementation outcomes of an HIV pre-exposure prophylaxis (PrEP) care strategy for patients seeking management of induced abortion and pregnancy loss.
SETTING: Single-center, urban, academic, hospital-based family planning service.
METHODS: We used a multifaceted implementation strategy directed toward family planning providers comprised of educational sessions, an electronic medical record-prompted verbal assessment of HIV risk, electronic medical record shortcuts for PrEP prescription, and support of a PrEP navigator. We assessed penetration of the intervention by calculating the penetration of a PrEP offer, measured as the proportion of encounters in which PrEP was offered to PrEP-eligible individuals. We evaluated feasibility, acceptability, and appropriateness of the intervention using belief elicitation interviews with providers.
RESULTS: From November 2018 to April 2019, the proportion of PrEP eligible patients who were offered PrEP, was 87.9% (29/33). Providers found the intervention acceptable and appropriate, but reported barriers including time constraints, and disappointment if patients did not adhere to PrEP. Providers liked that PrEP provision in abortion care settings felt innovative, and that they could contribute to HIV prevention.
CONCLUSION: Family planning providers in an academic center found HIV risk assessment and PrEP provision to be feasible, acceptable, and appropriate. Further research should evaluate implementation outcomes of PrEP care strategies in additional abortion care contexts, including clinics offering reproductive health care outside of academia.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35703764      PMCID: PMC9204783          DOI: 10.1097/QAI.0000000000002972

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  16 in total

1.  Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.

Authors:  Sarah K Calabrese; Tiara C Willie; Rachel W Galvao; Mehrit Tekeste; John F Dovidio; Cara B Safon; Oni Blackstock; Tamara Taggart; Clair Kaplan; Abigail Caldwell; Trace S Kershaw
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

2.  Awareness and Intent to Use Pre-exposure Prophylaxis (PrEP) Among African American Women in a Family Planning Clinic.

Authors:  Amy K Johnson; Faith E Fletcher; Emily Ott; Marisa Wishart; Eleanor E Friedman; Jessica Terlikowski; Sadia Haider
Journal:  J Racial Ethn Health Disparities       Date:  2019-12-17

3.  Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.

Authors:  Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Susan J Curry; Chyke A Doubeni; John W Epling; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2019-06-11       Impact factor: 56.272

4.  Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.

Authors:  Hsiu Wu; Maria C B Mendoza; Ya-Lin A Huang; Tameka Hayes; Dawn K Smith; Karen W Hoover
Journal:  Clin Infect Dis       Date:  2016-10-19       Impact factor: 9.079

5.  Incorporating HIV Pre-Exposure Prophylaxis Care for Patients Seeking Induced Abortion and Pregnancy Loss Management.

Authors:  Sarita Sonalkar; William R Short; Arden McAllister; Corinne Kete; Leah Ingeno; Jessica Fishman; Helen C Koenig; Courtney A Schreiber; Anne M Teitelman
Journal:  Womens Health Issues       Date:  2022-01-05

6.  HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami.

Authors:  Susanne Doblecki-Lewis; Larissa Lester; Bryanna Schwartz; Constance Collins; Rai Johnson; Erin Kobetz
Journal:  Int J STD AIDS       Date:  2015-09-18       Impact factor: 1.359

7.  Gaps in Preexposure Prophylaxis Uptake for HIV Prevention in the Veterans Health Administration.

Authors:  Will Garner; Brigid M Wilson; Lauren Beste; Marissa Maier; Michael E Ohl; Puja Van Epps
Journal:  Am J Public Health       Date:  2018-11       Impact factor: 9.308

8.  PrEP Stigma, HIV Stigma, and Intention to Use PrEP among Women in New York City and Philadelphia.

Authors:  Deepti Chittamuru; Victoria Frye; Beryl A Koblin; Bridgette Brawner; Hong-Van Tieu; Annet Davis; Anne Teitelman
Journal:  Stigma Health       Date:  2019-10-31

9.  A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project.

Authors:  Byron J Powell; Thomas J Waltz; Matthew J Chinman; Laura J Damschroder; Jeffrey L Smith; Monica M Matthieu; Enola K Proctor; JoAnn E Kirchner
Journal:  Implement Sci       Date:  2015-02-12       Impact factor: 7.327

10.  Exploring the heterogeneity of factors that may influence implementation of PrEP in family planning clinics: a latent profile analysis.

Authors:  Kaitlin N Piper; Regine Haardörfer; Cam Escoffery; Anandi N Sheth; Jessica Sales
Journal:  Implement Sci Commun       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.